Session Type
Meeting
Search Results for VTE
Oral Presentations
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: A variety of risk prediction scores have been devised to identify patients at increased risk for VTE in different patient populations and settings. Guideline recommendations for VTE risk assessment vary greatly. We performed a systematic review to identify and synthesize evidence on clinical risk prediction scores for VTE in medical and surgical hospitalized patients. […]
Oral Presentations
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Venous thromboembolism (VTE) is the leading cause of preventable hospital death. National guidelinesrecommend VTE prophylaxis for all medical patients not at low risk. Several VTE risk prediction models have been developed, but no US models have been validated in a medical population. The ACCP recommends use of the Padua risk assessment model with a […]
Oral Presentations
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Peripherally inserted central catheters (PICCs) have been associated with venous thromboembolism (VTE) and are a major cause of upper extremity deep vein thrombosis (DVT). However, mechanisms to identify patients at greatest risk of PICC-associated VTE are limited. Methods: Using data from the Michigan Hospital Medicine Safety consortium, patients with PICCs that experienced symptomatic, image-confirmed […]
Oral Presentations
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: A variety of risk prediction scores have been devised to identify patients at increased risk for VTE in different patient populations and settings. Guideline recommendations for VTE risk assessment vary greatly. We performed a systematic review to identify and synthesize evidence on clinical risk prediction scores for VTE in medical and surgical hospitalized patients. […]
Oral Presentations
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Venous thromboembolism (VTE) is the leading cause of preventable hospital death. National guidelinesrecommend VTE prophylaxis for all medical patients not at low risk. Several VTE risk prediction models have been developed, but no US models have been validated in a medical population. The ACCP recommends use of the Padua risk assessment model with a […]
Oral Presentations
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Peripherally inserted central catheters (PICCs) have been associated with venous thromboembolism (VTE) and are a major cause of upper extremity deep vein thrombosis (DVT). However, mechanisms to identify patients at greatest risk of PICC-associated VTE are limited. Methods: Using data from the Michigan Hospital Medicine Safety consortium, patients with PICCs that experienced symptomatic, image-confirmed […]
Abstract Number: 15
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: In 2016 70% of venous thromboembolism events at the University of Pittsburgh Medical Center Presbyterian Hospital occurred in patients with BMI>=25. The American College of Chest Physicians recommend weight base dosing for VTE prophylaxis in obese patients (grade 2C) as the standard dosing regimen may not be adequate for these patients. The anti-Xa range […]
Abstract Number: 86
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Clinical practice guidelines state that mobility is supposed to play an important role in determining use and duration of pharmacologic VTE prophylaxis. This study examines whether measured mobility levels relate to pharmacologic VTE prophylaxis use among hospitalized older adults. Methods: Prospective observational data from a sample of community-dwelling older adults aged ≥ 60 years, […]
Abstract Number: 88
SHM Converge 2021
Background: Research surrounding COVID-19 (coronavirus disease 2019) is rapidly increasing, including the study of biomarkers for predicting outcomes. There is little data examining the correlation between serum albumin levels and COVID-19 disease severity. The purpose of this study is to evaluate whether admission albumin levels reliably predict outcomes in COVID-19 patients. Methods: We retrospectively reviewed […]
Abstract Number: E9
SHM Converge 2022
Background: Arterial (3-fold) and venous (10-fold) thromboembolism are more common in myeloproliferative neoplasm (MPN) than general population with rates as high as 50% in polycythemia vera (PV) and essential thrombocythemia (ET).1,2 While primary prophylaxis with aspirin is not debated for prevention of arterial and venous thromboembolism, the choice of anticoagulant for secondary prophylaxis and treatment […]